The test has been validated for use with the same full set of female urogenital specimens that are used with Cobas NT/NG testing, as well as for use with male urine.
Among the firms reporting, BGI talked about plans to cut down the time and cost of its WGS service, and Invitae's CEO made a surprising proclamation about genetic testing.
Companies in the life science tools and molecular diagnostics spaces provided updates on their businesses at the 36th annual JP Morgan Healthcare Conference this week in San Francisco.
Genome Medical will use the proceeds of its Series A-1 financing to expand its nationwide footprint, as well as to invest in its telegenomics platform.
The newly launched LunaDNA hopes that its community model of compensating individuals for contributing genomic and health information will lead to better research.
The company has been working for several years under NIH grants totaling more than $7 million and is now preparing for its first formal product launch.
